Search

Your search keyword '"Rabenalt, R."' showing total 232 results
Start Over Author "Rabenalt, R."
232 results on '"Rabenalt, R."'

2. Quality of life after robotic-assisted and laparoscopic radical prostatectomy: Results of a multicenter randomized controlled trial (LAP-01)

Author

Holze, S., primary, Haney, C.M., additional, Lemaire, E., additional, Mende, M., additional, Neuhaus, P., additional, Arthanareeswaran, V-K-A., additional, Truss, M.C., additional, Do, H.M., additional, Dietel, A., additional, Teber, D., additional, Stützel, K.D., additional, Hohenfellner, M., additional, Rabenalt, R., additional, Albers, P., additional, and Stolzenburg, J-U., additional

Published
2022
Full Text
View/download PDF

4. Robotic-assisted versus laparoscopic surgery: Twelve-month outcomes from the first multicenter randomized patient blinded controlled trial in radical prostatectomy (LAP-01)

Author

Stolzenburg, J-U., primary, Holze, S., additional, Arthanareeswaran, V-K., additional, Neuhaus, P., additional, Do, H.M., additional, Haney, C.M., additional, Dietel, A., additional, Truss, M.C., additional, Stützel, K.D., additional, Teber, D., additional, Hohenfellner, M., additional, Rabenalt, R., additional, Albers, P., additional, and Mende, M., additional

Published
2021
Full Text
View/download PDF

36. Hyoscine butylbromide significantly decreases motion artefacts and allows better delineation of anatomic structures in mp-MRI of the prostate.

Author

Ullrich, T., Quentin, M., Schmaltz, A. K., Arsov, C., Rubbert, C., Blondin, D., Rabenalt, R., Albers, P., Antoch, G., and Schimmöller, L.

Subjects
MAGNETIC resonance imaging, PROSTATE cancer, ANTISPASMODICS, PROSTATE-specific antigen, SCOPOLAMINE
Abstract

Objectives: To prospectively evaluate the effect of hyoscine butylbromide (HBB) on visualisation of anatomical details and motion-related artefacts in mp-MRI of the prostate at 3.0 Tesla.Methods: One hundred and three consecutive patients (65 ± 10 years) were included in this trial, powered to demonstrate an improvement of image quality after HBB administration, assessed on a 5-point scale by two blinded readers. All patients received high-spatial resolution axial T2-weighted TSE sequences at 3.0 T without spasmolytic agent, repeated after application of 40 mg HBB and followed by routine mp-MRI. Secondary endpoints were (1) susceptibility to side effects, (2) dependence of spasmolytic effect on patients´ weight, and (3) prostate volume.Results: In 68% of patients, HBB significantly improved the anatomic score (mean 3.4 ± 0.9 before and 4.4 ± 0.7 after HBB for both readers, p = <0.001). In 67%, HBB significantly enhanced the artefact score (mean 3.2 ± 1 before and 4.2 ± 0.8 after HBB for reader 1, p = <0.001; 3.2 ± 1 and 4.1 ± 0.8 for reader 2, p = <0.001). Subgroup analysis revealed no statistically significant difference between patients with different bodyweight or prostate volume. Inter-reader agreement was excellent (k = 0.95-0.98).Conclusions: Hyoscine butylbromide significantly improves image quality and reduces motion-related artefacts in mp-MRI of the prostate independent of bodyweight or prostate volume. No side effects were reported.Key Points: • Hyoscine butylbromide (HBB) improved image quality in over 2/3 of patients. • Severe artefacts were reduced after HBB in more than 20%. • The number of non-diagnostic MRI was reduced to <1% after HBB. • HBB effect was independent of bodyweight and prostate volume. • No side effects of HBB were reported in this study population. [ABSTRACT FROM AUTHOR]

Published
2018
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results